Spinal Cord Trauma Treatment Market - Size, Industry Trends, Competitive Landscape, and Opportunities and Forecast 2022 - 2030
The Global Spinal Cord Trauma Treatment Market Size accounted for USD 3,771 Million in 2021 and is anticipated to reach USD 5,143 Million by 2030 with a CAGR of 3.6% from 2022 to 2030.
Damage to the spinal cord or the nerves at the cauda equina, the end of the spinal canal, can result in a spinal cord injury, which frequently results in permanent changes to strength, sensation, and other bodily functions below the site of the injury. The spinal cord transmits signals from the brain to the body's other organs. The spinal cord is enclosed and safeguarded by layers of tissue known as the meninges and a column of vertebrae (spinal bones). The most common cause of spinal cord injury is an abrupt, severe impact to the vertebrae. The spinal cord and its nerves are therefore harmed by the fractured (broken) bones. Rarely, a wound can split or totally sever the spinal cord.
Spinal Cord Trauma Treatment Market
Spinal Cord Trauma Treatment Market Size in 2021
US$ 593 Million
Spinal Cord Trauma Treatment Market Forecast By 2030
US$ 809 Million
Spinal Cord Trauma Treatment Market CAGR During 2022 – 2030
Spinal Cord Trauma Treatment Market Analysis Period
2018 - 2030
Spinal Cord Trauma Treatment Market Base Year
Spinal Cord Trauma Treatment Market Forecast Data
2022 - 2030
By Treatment Type, By Injurt, By End-User, and By Region
Spinal Cord Trauma Treatment Market Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled
Asterias Biotherapeutics, BioArctic AB, ReNetX Bio., BioTime, Inc., Kringle Pharma, Inc., and InVivo Therapeutics.
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
The most vital organ in the body, the spinal cord, is also the most susceptible to harm. The market for treating spinal cord trauma will rise as a result. The global market is expanding due to an increase in spinal cord-damaging sports injuries. The spinal cord's stability can also be harmed by heavy weight lifting. The market is also driven by investments made by businesses in the creation of trauma treatment centres in hospitals.
To counteract COVID-19, governments are pursuing a variety of actions. For example, the Centers for Disease Control and Prevention began collaborating with the All-of-Government and All-of-America Approach in May 2020 to boost testing capacity, case detection, and contact tracing across all states in the U.S., as well as to reopen the nation.
Additionally, United Spinal received a large gift from the Craig H. Neilsen Foundation in April 2020 to help those who have had hardships as a result of the COVID-19 pandemic and are living with spinal cord injuries and disorders (SCI/D).
The need for spinal cord trauma treatments has increased due to an increase in traffic accidents. Additionally, sedentary lifestyles have a negative impact on spinal health, which raises the chance of spine injuries. Therefore, a substantial growth in the spinal cord trauma therapy market is anticipated during the coming few years.
The three categories of the global spinal cord trauma treatment market are treatment type, injury, end-user, and region. The segmentation based on the treatment type includes surgery, corticosteroid, and spinal traction. In terms of treatment types, the corticosteroids is expected to grow with the fastest growth rate from 2022 to 2030. Based on injury, the market is categorized into complete spinal cord injury, partial spinal cord injury. End-user segment can be further divided into trauma centers, and hospitals.
Global Spinal Cord Trauma Treatment Market Geographical Competition
The North America, Europe, Latin America, Asian-Pacific, and the Middle East & Africa regions make up the five geographical segments of the global spinal cord trauma treatment market. The market for treating spinal cord trauma worldwide is anticipated to be dominated by the North American area. The presence of more important players in the region, the increased acceptance of cutting-edge spinal cord devices, and the government's active attempts to increase the use of these devices in healthcare settings are all elements that contribute to these regional dynamics. For instance, the U.S. FDA amended guidelines in September 2020 that emphasise doing trial stimulation prior to implanting a spinal cord stimulator. Such initiatives can support regional market expansion.
Global Spinal Cord Trauma Treatment Industry Segment Analysis
Market By Treatment Type
Market By Injury
Partial Spinal Cord Injury
Complete Spinal Cord Injury
Market By End-User
Spinal Cord Trauma Treatment Market Leading Companies
This section of the study honors the market's top vendors Asterias Biotherapeutics, BioTime, Inc., BioArctic AB, Kringle Pharma, Inc., ReNetX Bio., and InVivo Therapeutics.
Spinal Cord Trauma Treatment Market Regions
· Rest of Europe
· Rest of Latin America
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· South Africa
· Rest of Middle East & Africa